News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Vivek Subbiah highlights Deepak Bhamidipati’s poster on Project Optimus and early-phase trial design at AACR25
Vivek Subbiah/X
May 4, 2025, 13:37

Vivek Subbiah highlights Deepak Bhamidipati’s poster on Project Optimus and early-phase trial design at AACR25

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a post on X:

“Fantastic poster AACR25 by our newest Phase 1 clinical trial oncologist, Dr. Deepak Bhamidipati!
His first presentation post-fellowship highlights. The impact of Project Optimus and FDA guidance on early-phase trial design.
Join us in welcoming him to the drug development world.”

Learn more about drug development on OncoDaily.

AACR25 cancer Deepak Bhamidipati FDA OncoDaily Oncology Project Optimus the Sarah Cannon Research Institute Vivek Subbiah
Special Coverage
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference
Science
Aug 18, 2025, 16:33
Maria Tolia: New Study on Cardio-Oncology Considerations for Breast Cancer
Science
Aug 18, 2025, 16:25
The Findings from AICR and WCRF Research on World Breast Cancer Research Day